| 英文摘要 |
Insomnia is never simply a matter of“being unable to sleep”; it is a clinical phenomenon that surfaces at night once sleep, the body, emotion, cognition, and behavior fall out of balance. DSM-5, ICSD-3, and ICD-11 have progressively moved away from the“primary versus secondary”dichotomy toward a unified concept of insomnia disorder, defined by persistent difficulty initiating sleep, difficulty maintaining sleep, or early-morning awakening—accompanied by subjective distress or daytime impairment—despite adequate opportunity and a suitable environment for sleep. This integration improves clinical recognition, but it also gathers under one name patients who differ greatly in course, phenotype, comorbidity, and pathophysiology. The next step in assessment, therefore, is not to administer one more questionnaire, but to integrate subjective experience, temporal context, psychological and behavioral mechanisms, comorbidity risk, and multi-night objective signals. In recent years, insomnia assessment has been shifting from“a questionnaire plus a single night of polysomnography”toward precision phenotyping. Psychological phenotypes can be stratified by the level of distress, emotional reactivity, reward sensitivity, and life history, whereas neurophysiological phenotypes can combine objective sleep duration with non–rapid-eye-movement electroencephalographic spectral power to distinguish subtypes such as short sleep with deficient slow-wave activity, normal sleep duration with deficient slow-wave activity, and near-normal sleep macrostructure. Meanwhile, the high comorbidity of insomnia and obstructive sleep apnea (co-morbid insomnia and sleep apnea, COMISA) cautions us against treating only the complaint of sleeplessness or fixating solely on the apnea–hypopnea index. A new generation of contactless, non-wearable technologies opens a further observational window: a 24-GHz radar can measure chest-wall micromotion and respiration- and heartbeat-related signals without any bodily contact and, coupled with deep learning, estimate sleep state and abnormal respiratory events; the contactless sleep-apnea detection system that our team helped develop received Class II medical-device clearance from Taiwan’s Ministry of Health and Welfare in late 2025. Non-wearable devices such as smart mattresses can likewise capture respiration, heartbeat, and body movement, and can further analyze respiratory sinus arrhythmia (RSA) coupling to probe the interplay among autonomic function, slow-wave sleep, and emotional hyperarousal. This article proposes a tiered assessment pathway that is anchored in the clinical question, that moves from low burden to high resolution, and that extends from a single diagnostic encounter to long-term follow-up. For now, these technologies should be positioned as augmentative tools for screening, phenotyping, and monitoring rather than as replacements for the clinical interview or polysomnography. Genuine progress lies in transforming insomnia from a vague subjective label into an intelligible, trackable physiological dashboard that can guide individualized care—so that assessment becomes not a contest over who“sleeps worse,”but a way to read the language the body speaks at night. |